Pharmaceutical Accountability Foundation

Error 404

 
Sorry! We cannot find the page that you are looking for. Here are some useful links to get you started, or see our latest news below.

Recent News

“Six billion people have access to medicines today. So a lot...

Wilbert Bannenberg, Chair of the Pharmaceutical Accountability Foundation, was interviewed by the Volkskrant on his life's work: promoting global equitable access to medicines. The...

AbbVie tries to escape accountability for overcharging the Dutch healthcare system...

AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...

The Pharmaceutical Accountability Foundation’s case against AbbVie: The Facts

Version 15 November 2023 About Adalimumab/Humira and pricing issues AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the...

Answers to written Parliamentary questions by members Ellemeet and Westerveld (both...

Download the original (Dutch) here: antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload Download the English translation here: Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload